Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 336  

    Article Cited by others

ORIGINAL ARTICLE

Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors

Parghane Rahul V, Talole Sanjay, Basu Sandip

Year : 2019| Volume: 18| Issue : 2 | Page no: 160-170

   This article has been cited by
 
1 Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview
Andrea Cimini,Maria Ricci,Francesca Russo,Martina Egidi,Ferdinando Calabria,Antonio Bagnato,Orazio Schillaci,Agostino Chiaravalloti
Pharmaceuticals. 2021; 14(9): 872
[Pubmed]  [Google Scholar] [DOI]
2 Theranostics in Brain Tumors
Hossein Shooli,Reza Nemati,Hojjat Ahmadzadehfar,Mariam Aboian,Esmail Jafari,Narges Jokar,Iraj Nabipour,Habibollah Dadgar,Ali Gholamrezanezhad,Mykol Larvie,Majid Assadi
PET Clinics. 2021; 16(3): 397
[Pubmed]  [Google Scholar] [DOI]
3 Two Birds with One Stone: Skull Base Meningioma and Jugulotympanic Paragangliomas with Somatostatin Receptor Positron Emission Tomography
Giorgio Treglia,Mariana Raditchkova,Luca Giovanella,Jean-Jacques Stelmes,Davide G. Bosetti,Francesco Martucci
Diagnostics. 2021; 11(9): 1669
[Pubmed]  [Google Scholar] [DOI]
4 Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
Sandip Basu,Rahul V. Parghane,Rahul V. Kamaldeep,Sudipta Chakraborty
Seminars in Nuclear Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
5 The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors
Ilanah J. Pruis,Guus A. M. S. van Dongen,Sophie E. M. Veldhuijzen van Zanten
International Journal of Molecular Sciences. 2020; 21(3): 1029
[Pubmed]  [Google Scholar] [DOI]
6 Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists
Sandip Basu,Rahul Parghane,Rohit Ranade,Pradeep Thapa,Anant Ramaswamy,Vikas Ostwal,Bhawna Sirohi,Dipanjan Panda,Shailesh V Shrikhande
Indian Journal of Medical and Paediatric Oncology. 2019; 40(02): 165
[Pubmed]  [Google Scholar] [DOI]
7 Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center
Ludovica Magi,Federica Mazzuca,Maria Rinzivillo,Giulia Arrivi,Emanuela Pilozzi,Daniela Prosperi,Elsa Iannicelli,Paolo Mercantini,Michele Rossi,Patrizia Pizzichini,Andrea Laghi,Alberto Signore,Paolo Marchetti,Bruno Annibale,Francesco Panzuto
Journal of Clinical Medicine. 2019; 8(6): 910
[Pubmed]  [Google Scholar] [DOI]
8 Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications
Riccardo Laudicella,Domenico Albano,Salvatore Annunziata,Diletta Calabṛ,Giovanni Argiroffi,Elisabetta Abenavoli,Flavia Linguanti,Domenico Albano,Antonio Vento,Antonio Bruno,Pierpaolo Alongi,Matteo Bauckneht
Cancers. 2019; 11(10): 1412
[Pubmed]  [Google Scholar] [DOI]

 

Read this article